BOCCHIA MONICA
Contacts
0577586798
Teaching activities
Completion accademic year: 2026/2027
Completion accademic year: 2025/2026
Research
Ultime pubblicazioni:
- Caggiano, V., Sbalchiero, J., Frassi, M., Martin-Nares, E., Hinojosa-Azaola, A., Sikora, M., et al. (2026). Clinical and laboratory markers to distinguish VEXAS from Schnitzler's syndrome: data from the AIDA network registries. FRONTIERS IN MEDICINE, 12 [10.3389/fmed.2025.1659758]. - view more
- D'Amato, M., Rapolla, C.M., Benedetti, E., Bocchia, M., Capochiani, E., Carlomagno, G., et al. (2026). Real‑life diagnostic and therapeutic approach to CLL/SLL in tuscany: the 2025 consensus. CLINICAL AND EXPERIMENTAL MEDICINE, 26(1) [10.1007/s10238-026-02100-y]. - view more
- Gianesin, B., Zappu, A., Ferrero, G.B., Gaglioti, C.M., Santodirocco, M., Fania, G., et al. (2026). Real-world evidence supports the safety and efficacy profile of luspatercept in clinically complex and heavily iron-overloaded patients. BRITISH JOURNAL OF HAEMATOLOGY, 208(6), 2320-2325 [10.1111/bjh.70437]. - view more
- Tatangelo, V., Carullo, G., Lopresti, L., Ulivieri, C., Brogi, S., Butini, S., et al. (2026). Taginostat, a new quinolone-based HDAC6 inhibitor, promotes apoptosis of chronic lymphocytic leukemia cells in vitro and in vivo by activating STAT4. APOPTOSIS, 31(7) [10.1007/s10495-026-02393-0]. - view more
- Gavioli, F., Caggiano, V., Sbalchiero, J., Frassi, M., Crisafulli, F., Cavazzana, I., et al. (2026). VEXAS syndrome and cancer: Insights about a possible “Tip of the Iceberg”. Ambidirectional data from the international AIDA network registries. SEMINARS IN ARTHRITIS AND RHEUMATISM, 77 [10.1016/j.semarthrit.2026.152932]. - view more